Companies / Cinclus Pharma
Cinclus Pharma
Sweden
Cinclus Pharma develops small molecules for the treatment of gastric acid related diseases.
Cinclus Pharma, based in Sweden, has 2 investors on file, among them Claret Capital Partners and Eir Ventures. Its site was last checked 6 Nov 2026: site answers.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Investor | |
| Portfolio page | Venture capital |
More from Claret Capital Partners
91 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (20%), AI & Machine Learning (18%), Enterprise Software (8%).
See Claret Capital Partners' full profile · Who invests alongside it
More from Eir Ventures
16 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (100%).
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Cinclus Pharma and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Claret Capital Partners adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/cincluspharma.com/investors
# also
GET /v1/companies/cincluspharma.com
GET /v1/companies/cincluspharma.com/news